CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and can afford the risks. Trading CFDs is high risk and is not suitable for everyone. Refer to our PDS and Target Market Determination. AFSL 513393
Open platformOpen platform

Quaker Chemical Q3 sales, adj profit beat estimates on higher prices

By Reuters News


Overview

  • US industrial process fluids maker's Q3 sales rose 10%, beating analyst expectations

  • Adjusted EPS for Q3 rose 15% year-over-year and beat analyst expectations

  • Growth driven by higher prices and new business wins across all segments


Outlook

  • Company expects Q4 revenue and adjusted EBITDA to rise Y/Y but fall sequentially

  • Company expects soft Q4 demand in Asia due to uncertainty in China


Result Drivers

  • NEW BUSINESS WINS - Co said sales volume growth was driven by new business wins across all segments

  • PRICE AND PRODUCT MIX - Co said higher selling prices and product mix changes, including pricing actions to offset raw material costs, drove sales growth

  • EMEA MARGIN IMPROVEMENT - Co said EMEA segment operating earnings rose due to improved margins and higher net sales


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Beat

$544.55 mln

$520.83 mln (6 Analysts)

Q3 Adjusted EPS

Beat

$2.39

$2.10 (7 Analysts)

Q3 Adjusted Net Income

Beat

$41.41 mln

$36.98 mln (4 Analysts)

Q3 Adjusted EBITDA

Beat

$89.78 mln

$83.99 mln (7 Analysts)


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the commodity chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Quaker Chemical Corp is $195.00, about 24.3% above its October 28 closing price of $156.92

  • The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 20 three months ago


Reuters Recommended Reads

  • Oct 29 - Eastman Chemical Q3 revenue, profit miss analyst estimates on higher costs

  • Oct 27 - Illinois Tool Works Inc beats Q3 EPS estimates, raises 2026 outlook

  • Oct 28 - IDEX Q3 sales beat on increased volumes


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.